Dose-response assessment of four genotoxic chemicals in a combined mouse and rat micronucleus (MN) and Comet assay protocol

Journal of Toxicological Sciences

Volumn 35, Issue 2, 2010, Pages 149-162

  Recio, Leslie ^a   Hobbs, Cheryl ^a   Caspary, William ^b   Witt, Kristine L ^b  

^a ILS Inc ^*  (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Acrylamide; Comet assay; Cyclophosphamide; DNA damage; Ethyl methanesulfonate; Vincristine sulfate

Indexed keywords

ACRYLAMIDE; CYCLOPHOSPHAMIDE; MESYLIC ACID ETHYL ESTER; VINCRISTINE SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMET ASSAY; DNA DAMAGE; DUODENUM; GENOTOXICITY; IN VIVO STUDY; LEUKOCYTE; MALE; MICRONUCLEUS TEST; MOUSE; NONHUMAN; RAT; RETICULOCYTE;

ANIMALIA; MUS; RATTUS; RODENTIA;

EID: 77951662689     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.35.149     Document Type: Article

References (35)

1. Anderson, D., Bishop, J.B., Garner, R.C., Ostrosky-Wegman, P. and Selby, P.B. (1995): Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks. Mutat. Res., 330, 115-181.
2. Blakey, D., Galloway, S.M., Kirkland, D.J. and MacGregor, J.T. (2008): Regulatory aspects of genotoxicity testing: from hazard identification to risk assessment. Mutat. Res., 657, 84-90.
3. Bonassi, S., Znaor, A., Ceppi, M., Lando, C., Chang, W.P., Holland, N., Kirsch-Volders, M., Zeiger, E., Ban, S., Barale, R., Bigatti, M.P., Bolognesi, C., Cebulska-Wasilewska, A., Fabianova, E., Fucic, A., Hagmar, L., Joksic, G., Martelli, A., Migliore, L., Mirkova, E., Scarfi, M.R., Zijno, A., Norppa, H. and Fenech, M. (2007): An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis, 28, 625-631. (Pubitemid 46523357)
4. Burlinson, B., Tice, R.R., Speit, G., Agurell, E., Brendler-Schwaab, S.Y., Collins, A.R., Escobar, P., Honma, M., Kumaravel, T.S., Nakajima, M., Sasaki, Y.F., Thybaud, V., Uno, Y., Vasquez, M. and Hartmann, A. (2007): Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup. Mutat. Res., 627, 31-35.
5. Cushnir, J.R., Naylor, S., Lamb, J.H., Farmer, P.B., Brown, N.A. and Mirkes, P.E. (1990): Identification of phosphoramide mustard/ DNA adducts using tandem mass spectrometry. Rapid. Commun. Mass Spectrom., 4, 410-414.
6. Dearfield, K.L., Abernathy, C.O., Ottley, M.S., Brantner, J.H. and Hayes, P.F. (1988): Acrylamide: its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity. Mutat. Res., 195, 45-77.
7. Dertinger, S.D., Miller, R.K., Brewer, K., Smudzin, T., Torous, D.K., Roberts, D.J., Avlasevich, S.L., Bryce, S.M., Sugunan, S. and Chen, Y. (2007): Automated human blood micronucleated reticulocyte measurements for rapid assessment of chromosomal damage. Mutat. Res., 626, 111-119.
8. Dobrzyńska, M.M. (2007): Assessment of DNA damage in multiple organs from mice exposed to X-rays or acrylamide or a combination of both using the comet assay. In Vivo, 21, 657-662.
9. Doerge, D.R., da Costa, G.G., McDaniel, L.P., Churchwell, M.I., Twaddle, N.C. and Beland, F.A. (2005): DNA adducts derived from administration of acrylamide and glycidamide to mice and rats. Mutat. Res., 580, 131-141.
10. Eastmond, D.A., Hartwig, A., Anderson, D., Anwar, W.A., Cimino, M.C., Dobrev, I., Douglas, G.R., Nohmi, T., Phillips, D.H. and Vickers, C. (2009): Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS harmonized scheme. Mutagenesis, 24, 341-349.
11. Eastmond, D.A. and Tucker, J.D. (1989): Identification of ane-uploidy- inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody. Environ. Mol. Mutagen., 13, 34-43.
12. Elespuru, R.K., Agarwal, R., Atrakchi, A.H., Bigger, C.A., Heflich, R.H., Jagannath, D.R., Levy, D.D., Moore, M.M., Ouyang, Y, Robison, T.W., Sotomayor, R.E., Cimino, M.C. and Dearfield, K.L. (2009): Current and future application of genetic toxicity assays: the role and value of in vitro mammalian assays. Toxicol. Sci., 109, 172-179.
13. Fortini, P., Raspaglio, G., Falchi, M. and Dogliotti, E. (1996): Analysis of DNA alkylation damage and repair in mammalian cells by the Comet assay. Mutagenesis, 11, 169-175.
14. Gedik, C.M. and Collins, A. (2005): Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. FASEB J., 19, 82-84.
15. Ghanayem, B.I., Witt, K.L., Kissling, G.E., Tice, R.R. and Recio, L. (2005): Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-mediated effect. Mutat. Res., 578, 284-297.
16. Gocke, E. and Müller, L. (2009). In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU. Mutat. Res., 678, 101-107.
17. Guyton, K.Z., Kyle, A.D., Aubrecht, J., Cogliano, V.J., Eastmond, D.A., Jackson, M., Keshava, N., Sandy, M.S., Sonawane, B., Zhang, L., Waters, M.D. and Smith, M.T. (2009): Improving prediction of chemical carcinogenicity by considering multiple mechanisms and applying toxicogenomic approaches. Mutat. Res., 681, 230-240.
18. Hartmann, A., Agurell, E., Beevers, C., Brendler-Schwaab, S., Burlinson, B., Clay, P., Collins, A., Smith, A., Speit, G., Thybaud, V and Tice, R.R. (2003): Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis, 18, 45-51.
19. ICH (1996): International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) S2A: Guidance on specific aspects of regulatory genotoxicity tests for pharmaceuticals.
20. ICH (1997): International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) S2B: Genotoxicity: A standard battery for genotoxicity testing for pharmaceuticals.
21. ICH (2008): International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) S2(R1): Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use.
22. ILAR (1996): Institute of Laboratory Animal Resources Guide for the Care and Use of Laboratory Animals. National Academy of Sciences.
23. Kendall, M.G. (1938): A new measure of rank correlation. Biometrika, 30, 81-93.
24. Kirkland, D. and Speit, G. (2008): Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. Mutat. Res., 654, 114-132.
25. Lambert, I.B., Singer, T.M., Boucher, S.E. and Douglas, G.R. (2005): Detailed review of transgenic rodent mutation assays. Mutat. Res., 590, 1-280.
26. Manière, I., Godard, T., Doerge, D.R., Churchwell, M.I., Guffroy, M., Laurentie, M. and Poul, J.M. (2005): DNA damage and DNA adduct formation in rat tissues following oral administration of acrylamide. Mutat. Res., 580, 119-129.
27. Mann, H.B. and Whitney, D.R. (1947): On a test of whether one of two random variables is stochastically larger than the other. Ann. Math. Stat., 18, 50-60.
28. Pfuhler, S., Albertini, S., Fautz, R., Herbold, B., Madle, S., Utesch, D. and Poth, A. (2007): Genetic toxicity assessment: employing the best science for human safety evaluation part IV: Recommendation of a working group of the Gesellschaft fuer Umwelt- Mutationsforschung (GUM) for a simple and straightforward approach to genotoxicity testing. Toxicol. Sci., 97, 237-240.
29. Sumner, S.C., Williams, C.C., Snyder, R.W., Krol, W.L., Asgharian, B. and Fennell, T.R. (2003): Acrylamide: a comparison of metabolism and hemoglobin adducts in rodents following dermal, intraperitoneal, oral, or inhalation exposure. Toxicol. Sci., 75, 260-270.
30. Tice, R.R., Agurell, E., Anderson, D., Burlinson, B., Hartmann, A., Kobayashi, H., Miyamae, Y., Rojas, E., Ryu, J.C. and Sasaki, Y.F. (2000): Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen., 35, 206-221.
31. Tice, R.R., Furedi-Machacek, M., Satterfield, D., Udumudi, A., Vasquez, M. and Dunnick, J.K. (1998): Measurement of micro-nucleated erythrocytes and DNA damage during chronic ingestion of phenolphthalein in transgenic female mice heterozygous for the p53 gene. Environ. Mol. Mutagen., 31, 113-124.
32. U.S. EPA (2005): U.S. EPA. Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001F, Washington, DC.
33. Witt, K.L., Livanos, E., Kissling, G.E., Torous, D.K., Caspary, W., Tice, R.R. and Recio, L. (2008): Comparison of flow cytometry- and microscopy-based methods for measuring micronucleated reticulocyte frequencies in rodents treated with nongenotoxic and genotoxic chemicals. Mutat. Res., 649, 101-113.
34. Witt, K.L., Malarkey, D.E., Hobbs, C.A., Davis, J.P, Kissling, G.E., Caspary, W., Travlos, G. and Recio, L. (2009): No increases in biomarkers of genetic damage or pathological changes in heart and brain tissues in male rats administered methylphenidate hydrochloride (Ritalin) for 28 days. Environ. Mol. Mutagen., 51, 80-88.
35. Yang, H.J., Lee, S.H., Jin, Y., Choi, J.H., Han, C.H. and Lee, M.H. (2005): Genotoxicity and toxicological effects of acrylamide on reproductive system in male rats. J. Vet. Sci., 6, 103-109.